Organism	MIC range (mg/L (% susceptible)
	MSSA	MRSA	CNS	BHS	VS	Efc	Efm
N	351	201	206	640	114	66	138
DALa	0.015–0.12 [100]a	0.008–0.25 [100]	0.015–0.25 [100]	<0.004–0.25 [100]	<0.004–0.25 [100]	0.015–8 [99]	0.015->16 [83]
VAN	0.25–2 [100]	0.5–4 [100]	0.5–4 [100]	0.25–1 [100]	0.25–1 [100]	1->64 [99]	0.25->64 [82]
TEI	<0.12–2 [100]	<0.12–4 [100]	0.12–64 [98]	<0.12–0.25 [NA]b	<0.12–0.25 [NA]b	0.12->64 [99]	0.12->64 [83]
DAP	0.12–1 [100]	<0.12–1 [100]	<0.03–1 [100]	<0.12–1 [100]	<0.12–1 [100]	0.25–4 [100]	0.25–4 [100]
LZD	0.5–2 [100]	0.5–2 [100]	<0.5–2 [100]	<0.5–2 [100]	<0.5–2 [100]	1–2 [100]	1–2 [100]
SYN	<0.25–1 [100]	<0.25–1 [100]	<0.25–1 [100]	<0.25–1 [100]	<0.25–4 [92]	0.5->16 [2]	0.25–8 [61]
LEV	<0.12->16 [93]	<0.12->16 [13]	<0.12->16 [53]	0.12–8 [99.8]	0.12–2 [100]	0.25–16 [62]	0.12->16 [41]
ERY	0.12->32 [87]	0.12->32 [14]	<0.12->32 [37]	<0.12->32 [81]	<0.12->32 [74]	<0.12->32 [20]	0.12->32 [5]
TET	<0.25->16 [89]	<0.25->16 [59]	<0.25->16 [78]	<0.12->16 [52]	<0.12->16 [62]	0.25->16 [32]	0.25->16 [56]

^aFor dalbavancin projected susceptible breakpoints of ≤1 mg/L for staphylococci and enterococci; and ≤2 mg/L for streptococci were used

^bNA, CLSI breakpoints unavailable